US 7183267
β-lactamase inhibitors and methods of use thereof
granted A61KA61K31/381A61P
Quick answer
US patent 7183267 (β-lactamase inhibitors and methods of use thereof) held by Fulcrum Pharmaceuticals Inc. expires Mon Feb 22 2027 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Fulcrum Pharmaceuticals Inc.
- Grant date
- Tue Feb 27 2007 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 22 2027 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 21
- CPC classes
- A61K, A61K31/381, A61P, A61P31/04, A61P43/00